Arrowstreet Capital
AUPH icon

Arrowstreet Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Arrowstreet Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.7M Sell
3,284,368
-102,826
-3% -$1.5M 0.03% 497
2025
Q4 		$54M Buy
3,387,194
+13,173
+0.4% +$187K 0.03% 464
2025
Q3 		$37.3M Buy
3,374,021
+2,297,903
+214% +$25.1M 0.02% 544
2025
Q2 		$9.11M Sell
1,076,118
-564,314
-34% -$4.52M 0.01% 935
2025
Q1 		$13.2M Buy
1,640,432
+564,521
+52% +$4.57M 0.01% 730
2024
Q4 		$9.66M Buy
+1,075,911
New +$8.78M 0.01% 839

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return